Biotech News
Akribion Therapeutics Raises €8M to Advance RNA-Guided Cell Depletion Technology
Akribion Therapeutics, a biotechnology startup based in Zwingenberg, Germany, has announced its exit from stealth and the completion of an €8 million Seed financing round. The company is developing an RNA-guided, nuclease-based technology for programmable cell depletion, with an initial
5 February 2025